Consistent with our results, the severity of COVID-19 has also been linked to proinflammatory monocyte populations expressing CD169, which is upregulated upon activation and serves as an early marker for SARS-CoV-2 infection in patients requiring oxygen treatment (54, 61–63). The gene discussed is SIGLEC1; the disease is COVID-19.